Literature DB >> 6475499

Systemic amyloid myopathy--light-microscopic and fine-structural study of the skeletal muscles with histochemical and immunohistochemical study of amyloid.

K Ii, K Hizawa, S Nunomura, H Morizumi.   

Abstract

Studies were made on skeletal muscles obtained by biopsy and autopsy from a 59-year-old man with immunocyte dyscrasia and amyloidosis; he had progressive muscular stiffness with palpable tumors and chi-type Bence-Jones protein, but no overt myeloma. Histologically, much amyloid was seen deposited preferentially in the skeletal muscles, especially in the endo- and perimysia, forming tumors of various sizes and occasionally associating influx of amyloid into some muscle fibers, and in the smaller-sized blood vessel walls, frequently associated with extreme narrowing or occlusion of their lumina. Most muscle fibers were replaced by much amyloid or showed extensive atrophy, having a characteristic circular space under the endomysium, which was concluded to be not due to compression atrophy but to ischemic atrophy. Ischemic neuropathy was observed and seemed to be responsible for the diffuse atrophy without spaces seen exceptionally in some parts. Amyloid was shown histochemically to contain AL as the major protein component, immunohistochemically to have a close relation with chi-type light chain, and fine-structurally to be formed just outside the basement membrane of the blood vessels and deposited in the endo- and perimysia through perivascular infiltration. The clinicopathologic features of nine similar autopsy cases in the literature were compared with those in the present case. The causes of damage in muscle fibers and of preferential deposition of amyloid in the skeletal muscles were discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475499     DOI: 10.1007/bf00695574

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Amyloidosis.

Authors:  D C DAHLIN
Journal:  Proc Staff Meet Mayo Clin       Date:  1949-12-21

2.  Primary Amyloidosis Limited to Tissue of Mesodermal Origin.

Authors:  H A Reimann; R F Koucky; C M Eklund
Journal:  Am J Pathol       Date:  1935-11       Impact factor: 4.307

3.  An ABC of amyloid.

Authors:  J R Hobbs
Journal:  Proc R Soc Med       Date:  1973-07

4.  [Changes in the skeletal muscles following experimentally induced amyloidosis in mice].

Authors:  K Scheibner; W Meerbach
Journal:  Zentralbl Allg Pathol       Date:  1972

5.  Electron microscopic analysis of human amyloid.

Authors:  S Hirschl
Journal:  J Ultrastruct Res       Date:  1969-11

Review 6.  Structurally distinct collagen types.

Authors:  P Bornstein; H Sage
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

7.  Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber.

Authors:  B Mokri; A G Engel
Journal:  Neurology       Date:  1975-12       Impact factor: 9.910

8.  Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins.

Authors:  T Isobe; E F Osserman
Journal:  N Engl J Med       Date:  1974-02-28       Impact factor: 91.245

9.  Peri-collagenous amyloidosis. A study of 51 cases.

Authors:  J Hällén; R Rudin
Journal:  Acta Med Scand       Date:  1966-04

10.  Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease.

Authors:  R P Linke
Journal:  Clin Neuropathol       Date:  1982       Impact factor: 1.368

View more
  6 in total

1.  Amyloid myopathy with external ophthalmoparesis.

Authors:  Akihiko Hoshi; Masahiro Ebitani; Gaku Tanaka; Kouichirou Nakamura; Ken Shibano; Nozomu Matsuda; Masafumi Abe; Yoshikazu Ugawa
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

2.  Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathy.

Authors:  M C Dalakas; G Cunningham
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  Early sarcolemmal dysfunction in skeletal muscle amyloidosis.

Authors:  C Doriguzzi; T Mongini; W Troni; G Monga
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

4.  Myopathy in primary systemic amyloidosis.

Authors:  M A Gertz; R A Kyle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

5.  Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy.

Authors:  K Li; R A Kyle; P J Dyck
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

6.  Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.

Authors:  Mirela Draghici; Andreea Jercan; Sorina Nicoleta Badelita; Ruxandra Maria Irimia; Alexandra Eugenia Bastian; Camelia Dobrea; Monica Popescu; Daniel Coriu
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.